06/03/2026
⚠️ Important reading for anyone in transportation, safety, or workforce compliance.
As ma*****na rescheduling moves forward in 2026, a new paper by three leading medical and legal experts cuts through the noise with hard science and real-world data.
Authors: 👨⚕️ Todd Simo, MD — President of the American Association of Medical Review Officers 👩⚕️ Melissa Snider-Adler, MD — Board Member of the Medical Review Officer Certification Council ⚖️ Patrice Kelly, JD — President, Patrice Kelly Consulting, LLC
Two myths they debunk — and why it matters for public safety:
🚫 "Ma*****na is basically as safe as alcohol." Partly true, partly dangerous. Yes, a direct fatal THC overdose is rare. But ma*****na impairment is less predictable, lasts longer, and can persist even after someone feels completely sober. Studies show workers who test positive for ma*****na have 55% more industrial accidents, 85% more injuries, and 75% greater absenteeism than those who test negative. After ma*****na legalization in several states, fatal crash rates increased by 4.1%.
🚫 "If someone passes a drug test, they're not impaired." Drug tests detect use, not impairment. THC stores in fat and brain tissue and releases slowly — meaning someone can test within acceptable limits and still have significant cognitive impairment affecting their judgment, coordination, and reaction time.
DOT-regulated testing has prevented ma*****na-related fatalities in commercial transportation for 35+ years. That program — and the public safety it protects — must be preserved as rescheduling moves forward.
📖 Read the full paper: https://bit.ly/3PXRgxu
